Sun Pharma Acquires Concert Pharmaceuticals to Broaden its Dermatology Portfolio

By Ayush Saxena

Pharma Deals Review: Vol 2023 Issue 2 (Table of Contents)

Published: 1 Feb-2023

DOI: 10.3833/pdr.v2023.i2.2760     ISSN: 1756-7874

Section: Mergers & Acquisitions



In a bid to expand its dermatology portfolio, Sun Pharma has agreed to buy Concert Pharmaceuticals under which Sun Pharma will acquire all outstanding shares of Concert through a tender offer for an upfront payment of US$8 per share of common stock in cash or US$576 M in equity value...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details